SUPN Q1 2026 Earnings Strong EPS Beat Drives 977 Surprise Despite Stock Decline UPXI Q1 2026 Earnings Massive EPS Miss Sends Stock Lower Reviva Pharmaceuticals RVPH Q1 2026 Earnings EPS Beats Estimates as Cost Discipline Drives SmallerThanExpected Loss APAM Q1 2026 Earnings EPS Misses Consensus as Market Headwinds Persist JPM Q1 2026 Earnings Strong EPS Beat Despite Subdued Revenue Environment REAX Q1 2026 Earnings Narrowing Losses with Strong Earnings Beat